Redmile Group LLC 13D and 13G filings for IGM Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-28 5:15 pm Purchase |
2023-06-26 | 13D | IGM Biosciences, Inc. IGMS |
Redmile Group LLC | 3,291,092 9.900% |
257,595 (+8.49%) |
Filing |
| 2023-06-13 5:15 pm Sale |
2023-06-12 | 13D | IGM Biosciences, Inc. IGMS |
Redmile Group LLC | 3,033,497 10.300% |
-343,593 (-10.17%) |
Filing |
| 2022-10-05 5:00 pm Purchase |
2022-10-03 | 13D | IGM Biosciences, Inc. IGMS |
Redmile Group LLC | 3,377,090 11.600% |
14,630 (+0.44%) |
Filing |
| 2022-04-05 5:09 pm Sale |
2022-04-01 | 13D | IGM Biosciences, Inc. IGMS |
Redmile Group LLC | 3,362,460 12.900% |
-75,572 (-2.20%) |
Filing |
| 2020-12-15 4:14 pm Purchase |
2020-12-11 | 13D | IGM Biosciences, Inc. IGMS |
Redmile Group LLC | 3,438,032 13.500% |
8,216 (+0.24%) |
Filing |
| 2020-09-09 8:29 pm Purchase |
2020-09-09 | 13D | IGM Biosciences, Inc. IGMS |
Redmile Group LLC | 3,429,816 14.200% |
285,816 (+9.09%) |
Filing |